WEBULL

Should Chemtrade’s Extended North Vancouver Chlorine Operations and Safety Covenant Reshape the (TSX:CHE.UN) Investment Thesis?

Simply Wall St · 2d ago
  • Chemtrade Logistics Income Fund recently secured final approval for the rezoning of its North Vancouver chlor-alkali facility, allowing liquid chlorine production to continue until the earlier of its Vancouver Fraser Port Authority lease expiry or 2046 and enabling planned safety upgrades under a new restrictive covenant with the District.
  • This agreement not only extends operational certainty for a key asset, but also formalizes community oversight and safety reporting, potentially reducing regulatory overhang and reputational risk.
  • We’ll now explore how this extended North Vancouver operating horizon and associated safety commitments may influence Chemtrade’s existing investment narrative.

AI is about to change healthcare. These 7 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Chemtrade Logistics Income Fund Investment Narrative Recap

Chemtrade’s story still rests on a simple thesis: a cash generative chemicals platform gradually tilting toward more resilient water treatment and specialty acid, while managing debt and input cost volatility. The North Vancouver rezoning strengthens the durability of a key chlor alkali asset, but it does not materially alter the near term focus on earnings execution and sulfur related cost risk that could pressure margins if pricing lags.

Against that backdrop, Chemtrade’s ongoing share buyback program stands out as the most relevant recent development. By May 2026 the fund had repurchased roughly 4.6 percent of its units for about CA$70.3 million, alongside steady monthly distributions of CA$0.06 per unit. Together with the longer operating horizon at North Vancouver, these capital returns frame how management is currently balancing balance sheet priorities with shareholder payouts.

Yet, against this more confident setup, investors should be aware that input cost volatility and fixed price contracts can still compress margins when...

Read the full narrative on Chemtrade Logistics Income Fund (it's free!)

Chemtrade Logistics Income Fund's narrative projects CA$2.4 billion revenue and CA$216.2 million earnings by 2029. This requires 6.4% yearly revenue growth and a CA$100.5 million earnings increase from CA$115.7 million today.

Uncover how Chemtrade Logistics Income Fund's forecasts yield a CA$19.75 fair value, a 17% upside to its current price.

Exploring Other Perspectives

TSX:CHE.UN 1-Year Stock Price Chart
TSX:CHE.UN 1-Year Stock Price Chart

Before the rezoning news, the most optimistic analysts were assuming revenue could reach about CA$2.5 billion with earnings near CA$203 million, a far more upbeat view than consensus, especially if safety focused capital at sites like North Vancouver really does help underpin uptime and margins over time.

Explore 4 other fair value estimates on Chemtrade Logistics Income Fund - why the stock might be worth just CA$19.75!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

Curious About Other Options?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.